1. Home
  2. CING vs CRGO Comparison

CING vs CRGO Comparison

Compare CING & CRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CING

Cingulate Inc.

HOLD

Current Price

$5.21

Market Cap

64.5M

Sector

Health Care

ML Signal

HOLD

Logo Freightos Limited Ordinary shares

CRGO

Freightos Limited Ordinary shares

HOLD

Current Price

$1.19

Market Cap

66.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CING
CRGO
Founded
2012
2012
Country
United States
Spain
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
64.5M
66.7M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
CING
CRGO
Price
$5.21
$1.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$34.50
$2.40
AVG Volume (30 Days)
133.6K
246.3K
Earning Date
05-08-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
56.47
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.61
Revenue Next Year
N/A
$16.85
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.16
$1.14
52 Week High
$11.89
$4.24

Technical Indicators

Market Signals
Indicator
CING
CRGO
Relative Strength Index (RSI) 52.86 41.69
Support Level $5.08 $1.17
Resistance Level $5.54 $1.43
Average True Range (ATR) 0.31 0.09
MACD -0.04 -0.01
Stochastic Oscillator 27.17 3.45

Price Performance

Historical Comparison
CING
CRGO

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About CRGO Freightos Limited Ordinary shares

Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters, thousands of forwarders, and dozens of airlines and ocean carriers. The company operates in two segments: the Platform segment and the Solutions segment. The majority of the revenue is derived from the Solutions segment, which provides software tools and data to help industry participants automate their pricing, sales, and procurement processes. Geographically, it generates the maximum revenue from Europe, and the rest from the United States, Hong Kong and Others.

Share on Social Networks: